Remodeling of tissue-engineered bone structures in vivo.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Optimizing implant design for bone regeneration requires matching scaffold structure to defect site anatomy.
• Silk fibroin scaffolds with RGD sequences (SF-RGD) offer a promising platform for bone tissue engineering.

Purpose of the Study:

• To investigate if in vitro engineered bone-like structures, mimicking different pore sizes, enhance bone regeneration after implantation.
• To assess the impact of engineered bone geometry on healing in mouse calvarial defects.

Main Methods:

• Porous SF-RGD scaffolds with small, medium, and large pore sizes were seeded with hMSC and differentiated in vitro.
• Engineered tissues were implanted into mouse calvarial defects for 8 weeks.
• Histological analysis evaluated bone formation, vascularization, and remodeling.

Main Results:

• In vitro engineered tissues remodeled into bone with varying woven/lamellar proportions, bridging defects.
• All implants demonstrated good integration, advanced vascularization, and bone marrow ingrowth, irrespective of pore size.
• The initial geometry (trabecular- or plate-like) of the engineered bone did not significantly affect defect healing.

Conclusions:

• The geometry of in vitro engineered bone structures has a limited impact on bone defect healing in this model.
• Efficient in vivo remodeling compensates for initial structural differences, highlighting the adaptability of engineered bone.
• Silk fibroin scaffolds support robust bone regeneration and vascularization, regardless of scaffold pore size or resulting engineered tissue geometry.